Answers are grounded in this paper and cite their sources.
"Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma." Leukemia & Lymphoma, 56(7), pp. 2185–2186
No takes yet. Share an insight, caveat, or question.
Chan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: